Molecular Cancer Research Targeting the PI3-Kinase Pathway in Cancer Chemical and Biological Aspects of Inflammation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kurtz, A.
Right arrow Articles by Wong, L.-J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurtz, A.
Right arrow Articles by Wong, L.-J. C.
Molecular Cancer Research 2:433-441 (2004)
© 2004 American Association for Cancer Research


Cancer Genes and Genomics

Somatic Mitochondrial DNA Mutations in Neurofibromatosis Type 1-Associated Tumors1

Andreas Kurtz1, Maria Lueth2, Lan Kluwe3, Tingguo Zhang1, Rosemary Foster1, Victor-Felix Mautner3, Melanie Hartmann4, Duan-Jun Tan2, Robert L. Martuza1, Reinhard E. Friedrich3, Pablo Hernáiz Driever4 and Lee-Jun C. Wong2

1 Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts; 2 Institute for Molecular and Human Genetics, Georgetown University Medical Center, Washington, District of Columbia; 3 University Hospital Eppendorf, Hamburg, Germany; and 4 Charité Medical Center, Humboldt University, Berlin, Germany

Requests for reprints: Lee-Jun C. Wong, Institute for Molecular and Human Genetics, Georgetown University Medical Center, 3800 Reservoir Road, M4000, Washington, DC 20007. Phone: 202-444-0760; Fax: 202-444-1770. E-mail: wonglj{at}georgetown.edu

Neurofibromatosis type 1 is an autosomal dominantly inherited disease predisposing to a multitude of tumors, most characteristically benign plexiform neurofibromas and diffuse cutaneous neurofibromas. We investigated the presence and distribution of somatic mitochondrial DNA (mtDNA) mutations in neurofibromas and in nontumor tissue of neurofibromatosis type 1 patients. MtDNA alterations in the entire mitochondrial genome were analyzed by temporal temperature gradient gel electrophoresis followed by DNA sequencing. Somatic mtDNA mutations in tumors were found in 7 of 19 individuals with cutaneous neurofibromas and in 9 of 18 patients with plexiform neurofibromas. A total of 34 somatic mtDNA mutations were found. All mutations were located in the displacement loop region of the mitochondrial genome. Several plexiform neurofibromas from individual patients had multiple homoplasmic mtDNA mutations. In cutaneous neurofibromas, the same mtDNA mutations were always present in tumors from different locations of the same individual. An increase in the proportion of the mutant mtDNA was always found in the neurofibromas when compared with nontumor tissues. The somatic mtDNA mutations were present in the Schwann cells of the analyzed multiple cutaneous neurofibromas of the same individual. The observed dominance of a single mtDNA mutation in multiple cutaneous neurofibromas of individual patients indicates a common tumor cell ancestry and suggests a replicative advantage rather than random segregation for cells carrying these mutated mitochondria.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2004 by the American Association for Cancer Research.